Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture. (NCT04683887) | Clinical Trial Compass
CompletedNot Applicable
Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture.
Italy23 participantsStarted 2021-06-25
Plain-language summary
Wrist fractures are a very common event affecting patients of all ages and are estimated to account for approximately 10% -25% of all fractures. 70-90% of fractures are treated with closed reduction and forearm cast. In 2019, 17.4% of wrist fractured patients treated with a plaster cast at the Orthopedic Emergency Department (OED) of the Local Health Unit ("Azienda Unità Sanitaria Locale", AUSL) of Piacenza had a second access to the OED for edema, pain or "intolerance to the plaster cast ".
In literature, there are several studies that demonstrate the effectiveness of adhesive elastic tape for edema control, mostly lymphedema secondary to breast cancer or post-operative edema after knee arthroplasty, although a definitive evidence is still needed.
With this trial, the investigators aim to evaluate the tape effectiveness in counteracting hand edema formation in wrist fractured adult patients treated with forearm cast.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with growth plates closed on radiographic examination
* Unilateral distal radius fracture associated or not with ulnar styloid fracture
* Wrist fracture requiring bloodless reduction and immobilization with a forearm cast
Exclusion Criteria:
* Patients with multiple fractures
* Polytrauma patients
* Patients with previous plegia / paralysis of the fractured limb
* Patients with previous lymphedema of the fractured limb
* Patients with access to the OED during the night when the organization does not guarantee the presence of 2 nurses
* Wounds or abrasions in the area of application of the tape
* Acute thrombosis (upper limb veins)
* Scars not perfectly healed in the area of application of the tape
* Dermatitis, psoriatic manifestations or erythema in the area of application of the tape
* Known allergy to acrylic (patch glue)
* Solid neoplasms
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.